Cabaletta Bio (CABA) Exchange Rate Effect (2024 - 2025)
Cabaletta Bio (CABA) recorded quarterly Exchange Rate Effect of -$8000.0 in Q4 2025, up 27.27% quarter-over-quarter from -$11000.0 in Q3 2025, and up 60.0% on a YoY basis from -$5000.0 in Q4 2024.
Cabaletta Bio (CABA) Exchange Rate Effect (2024 - 2025) Analysis & Trends
Cabaletta Bio's Exchange Rate Effect history runs 2 years deep, the most recent figure standing at -$8000.0 for Q4 2025.
- In Q4 2025, Exchange Rate Effect rose 60.0% year-over-year to -$8000.0; the TTM figure through Dec 2025 stood at $19000.0 (up 195.0% YoY), while the FY2025 annual figure was $19000.0, up 195.0% from the prior year.
- Exchange Rate Effect was -$8000.0 for Q4 2025 at Cabaletta Bio, up from -$11000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $31000.0 in Q2 2025 to a low of -$20000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | -8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | -20,000.00 |
| Dec 31, 2024 | -20,000.00 |